Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Line S. Tarpgaard"'
Autor:
Mojib Fallah, Sönke Detlefsen, Alan P. Ainsworth, Claus W. Fristrup, Michael B. Mortensen, Per Pfeiffer, Line S. Tarpgaard, Martin Graversen
Publikováno v:
Pleura and Peritoneum. 7:143-148
Objectives The four-tiered peritoneal regression grading score (PRGS) is used for histological response evaluation in patients with peritoneal metastasis (PM) treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Four quadrant biopsi
Autor:
Line S Tarpgaard, Tormod K Guren, Bengt Glimelius, Ib J Christensen, Per Pfeiffer, Elin H Kure, Halfdan Sorbye, Tone Ikdahl, Mette Yilmaz, Julia S Johansen, Kjell Magne Tveit
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e87746 (2014)
We aim to test the hypothesis that high plasma YKL-40 is associated with short progression-free survival (PFS) and overall survival (OS) in patients with metastatic colorectal cancer (mCRC) treated with first-line oxaliplatin and 5-flourouracil with
Externí odkaz:
https://doaj.org/article/5220fea8fbdf4802a9079ec55874bed7
Autor:
Mogens K Boisen, Christian Dehlendorff, Dorte Linnemann, Boye S Nielsen, Jim S Larsen, Kell Osterlind, Svend E Nielsen, Line S Tarpgaard, Camilla Qvortrup, Per Pfeiffer, Niels H Holländer, Nina Keldsen, Torben F Hansen, Brita B Jensen, Estrid V S Høgdall, Benny V Jensen, Julia S Johansen
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e109430 (2014)
PURPOSE: We tested the hypothesis that expression of microRNAs (miRNAs) in cancer tissue can predict effectiveness of bevacizumab added to capecitabine and oxaliplatin (CAPEOX) in patients with metastatic colorectal cancer (mCRC). EXPERIMENTAL DESIGN
Externí odkaz:
https://doaj.org/article/6cd8372b3db94d9ebca0c391d81dd6a1
Autor:
Line S, Tarpgaard, Ib J, Christensen, Gunilla, Høyer-Hansen, Ida K, Lund, Tormod K, Guren, Bengt, Glimelius, Halfdan, Sorbye, Kjell M, Tveit, Hans Jørgen, Nielsen, José M A, Moreira, Per, Pfeiffer, Nils, Brünner
Publikováno v:
International journal of cancer. 137(10)
Circulating forms of the urokinase plasminogen activator receptor (uPAR) are associated with prognosis in patients with colorectal cancer. Preclinical studies have shown that uPAR can influence the state of phosphorylation and signalling activity of